272776-96-2

Upstream product

• 272776-90-6 (5R)-5-(t-butyldimethylsilyl)oxy-1-(4-methoxybenzyl)oxynona-8-en-2-yne 
• 272776-92-8 (2Z)-(5R)-5-(t-butyldimethylsilyl)oxy-3-iodonona-2,8-dien-1-ol 
• 272776-89-3 (5R)-1-(4-methoxybenzyl)oxynona-8-en-2-yn-5-ol 
• 272776-93-9 (2Z)-(5R)-2-[5-(t-butyldimethylsilyl)oxy-2-methylenecyclohexylidene]ethanol 
• 272776-94-0 (2Z)-(5R)-2-[5-(t-butyldimethylsilyl)oxy-2-methylenecyclohexylidene]-1-chloroethane 
• 272776-91-7 (5R)-5-(t-butyldimethylsilyl)oxynona-8-en-2-yn-1-ol 
• 272776-88-2 1-(4-methoxybenzyloxy)-4-[(2S)-oxiran-2-yl]-2-butyne 
• 272776-95-1 (2Z)-(5R)-[2-[5-(t-butyldimethylsilyl)oxy-2-methylenecyclohexylidene]ethyl]diphenylphosphine oxide 
• 239100-32-4 (1R,3aR,4S,7aR)-1-[(1R,4R)-4,5-di(tert-butyldimethylsilyloxy)-1,5-dimethylhexyl]-7a-methyloctahydro-1H-inden-4-one 

Downstream Products

• 272776-87-1 (5Z,7E)-(3R,24R)-9,10-secocholesta-5,7,10⁽¹⁹⁾-triene-3,24,25-triol 

Relevant academic research and scientific papers

Characterization of new conjugated metabolites in bile of rats administered 24,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3

The characterization of new conjugated vitamin D metabolites in rat bile was performed using HPLC, liquid chromatography/tandem mass spectrometry combined derivatization, and GC-MS. After the administration of 24,25- dihydroxyvitamin D3 to rats